{"path":".obsidian/plugins/text-extractor/cache/834cb06dc013f2ec0d96cc0c83202f5f.json","text":"CAHPTER 01 . FK506 (Tacrolimus) O FK-506 (also Tacrolimus or Fujimycin) is an immunosuppressive drug whose main use is after allogeneic organ transplant to reduce the activity of the patient's immune system and so lower the risk of o organ rejection. Ha, = L] @b Qltis also used in a topical preparation in the . O {_M treatment of severe atopic dermatitis (eczema), - I \" severe refractory uveitis after bone marrow 0 transplants, and the skin condition vitiligo. 0 &M Qltis a 23-membered macrolide lactone discovered f N in 1984 from the fermentation broth of a Japanese N o) soil sample that contained the bacteria o £ Streptomyces tsukubaensis. Ho Q |t was first approved by the Food and Drug - Administration (FDA) in 1994 for use in liver T transplantation; this has been extended to include o— kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, bone marrow, and limb transplants. From Wikipedia","libVersion":"0.2.2","langs":"eng"}